# VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness

> **NCT00467441** · PHASE2 · COMPLETED · sponsor: **Vanda Pharmaceuticals** · enrollment: 60 (estimated)

## Conditions studied

- Excessive Somnolence

## Interventions

- **DRUG:** VSF-173

## Key facts

- **NCT ID:** NCT00467441
- **Lead sponsor:** Vanda Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2007-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00467441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00467441, "VSF-173 Study in Healthy Adult Volunteers for Treatment of Induced Excessive Sleepiness". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00467441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*